Jane Street Group, LLC Ptc Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $352,524 - $436,855	11,600 New	11,600 $430,000
Q1 2022 May 17, 2022	SELL	$33.33 - $44.6 $69,993 - $93,660	-2,100 Reduced 22.83%	7,100 $265,000
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $68,310 - $88,866	-1,800 Reduced 16.36%	9,200 $389,000
Q1 2021 May 18, 2021	SELL	$46.8 - $68.92 $60,839 - $89,596	-1,300 Reduced 10.57%	11,000 $521,000
Q4 2020 Feb 17, 2021	SELL	$47.96 - $67.64 $1.07 Million - $1.51 Million	-22,300 Reduced 64.45%	12,300 $751,000
Q3 2020 Nov 17, 2020	BUY	$45.41 - $57.07 $949,068 - $1.19 Million	20,900 Added 152.55%	34,600 $1.62 Million
Q2 2020 Aug 17, 2020	SELL	$42.56 - $54.98 $187,264 - $241,912	-4,400 Reduced 24.31%	13,700 $695,000
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $612,142 - $871,877	18,100 New	18,100 $612,000
Q4 2018 Feb 15, 2019	SELL	$29.83 - $46.51 $149,150 - $232,550	-5,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $169,500 - $238,850	5,000 New	5,000 $235,000
Q4 2017 Feb 15, 2018	SELL	$15.14 - $20.89 $233,156 - $321,706	-15,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $258,873 - $332,794	15,400	15,400 $308,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.